Investment | Actis invests in leading Maghreb Pharmaceutical business Medis
TUNISA, Capital Markets in Africa: Actis, a leading growth markets investor, today announced a significant investment in Medis Group (Medis), a prominent branded generic pharmaceuticals business in Tunisia and Algeria. Actis has acquired a meaningful stake in the business from Africinvest, one of the key PanAfrican Mid-cap PE players, and from the founding Boujbel family. Actis will also inject further funds into the business to finance a buy-and-build strategy to create a leading pan- African…
Read More